BPC-157: A MAHA-Adjacent Peptide, Linked to Croatia US$ 24.02 Min. order: 1 piece ★★★★★ 4.1 (171 reviews) Sold : Login>>
CagriSema, Novo Nordisk's Latest Obesity Drug Offering, Disappoints Investors with Trial Results US$ 21.74 Min. order: 1 piece ★★★★★ 4.7 (152 reviews) Sold : Login>>
CagriSema Yields Nearly 16% Weight Loss in Phase 3 REDEFINE 2 Trial US$ 22.40 Min. order: 1 piece ★★★★★ 4.6 (195 reviews) Sold : Login>>
The pharma race to develop increasingly more potent incretin-based therapeutics—what is for the clinicians to know US$ 27.58 Min. order: 1 piece ★★★★★ 4.7 (256 reviews) Sold : Login>>
CagriSema- SEMAGLUTIDE IN ADULTS WITH OVERWEIGHT OR OBESITY AND TYPE 2 DIABETES MELLITUS.pptx US$ 27.37 Min. order: 1 piece ★★★★★ 4.6 (114 reviews) Sold : Login>>